世界における末梢塞栓保護デバイスの製品パイプライン動向2015

GlobalDataが発行した調査報告書(GDME0052EPD)
◆英語タイトル:Peripheral Embolic Protection Devices - Pipeline Review, 2015
◆商品コード:GDME0052EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年7月28日
◆ページ数:73
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、末梢塞栓保護デバイスのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・末梢塞栓保護デバイスの概要
・末梢塞栓保護デバイスの開発動向:開発段階別分析
・末梢塞栓保護デバイスの開発動向:領域別分析
・末梢塞栓保護デバイスの開発動向:規制Path別分析
・末梢塞栓保護デバイスの開発動向:承認日(推定)別分析
・企業別末梢塞栓保護デバイスの開発動向(パイプライン製品、進行中の治験)
・末梢塞栓保護デバイスの最近動向
【レポートの概要】

Peripheral Embolic Protection Devices – Pipeline Review, 2015

Summary

GlobalData’s Medical Devices sector report, “Peripheral Embolic Protection Devices – Pipeline Review, 2015″ provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Embolic Protection Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Peripheral Embolic Protection Devices Overview 7
3 Products under Development 8
3.1 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 8
3.2 Peripheral Embolic Protection Devices – Pipeline Products by Segment 9
3.3 Peripheral Embolic Protection Devices – Pipeline Products by Territory 10
3.4 Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 11
3.5 Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 12
3.6 Peripheral Embolic Protection Devices – Ongoing Clinical Trials 13
4 Peripheral Embolic Protection Devices – Pipeline Products under Development by Companies 14
4.1 Peripheral Embolic Protection Devices Companies – Pipeline Products by Stage of Development 14
4.2 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 15
5 Peripheral Embolic Protection Devices Companies and Product Overview 16
5.1 Abbott Vascular Inc. Company Overview 16
5.1.1 Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 AngioDynamics, Inc. Company Overview 20
5.2.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Cardio-Flow Ltd. Company Overview 22
5.3.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 CardioGard Ltd. Company Overview 23
5.4.1 CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 CardioLogical Solutions Company Overview 24
5.5.1 CardioLogical Solutions Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Claret Medical, Inc. Company Overview 26
5.6.1 Claret Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Gardia Medical Ltd. Company Overview 30
5.7.1 Gardia Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Innovative Cardiovascular Solutions, LLC Company Overview 32
5.8.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Innovia LLC Company Overview 34
5.9.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Keystone Heart Ltd. Company Overview 35
5.10.1 Keystone Heart Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Medtronic plc Company Overview 40
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Metactive Medical, LLC Company Overview 44
5.12.1 Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 MIV Therapeutics Inc Company Overview 46
5.13.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 NeuroInterventions Company Overview 48
5.14.1 NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview 48
5.15 Neurosonix Ltd. Company Overview 50
5.15.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
5.16 Nexeon MedSystems, Inc. Company Overview 52
5.16.1 Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.17 Palmaz Scientific, Inc. Company Overview 54
5.17.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.18 Trinity College Dublin Company Overview 56
5.18.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 56
5.19 University of Minnesota Company Overview 58
5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 58
5.20 University of Toledo Company Overview 60
5.20.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 60
6 Peripheral Embolic Protection Devices- Recent Developments 62
7 Appendix 70
7.1 Methodology 70
7.2 About GlobalData 72
7.3 Contact Us 72
7.4 Disclaimer 73

1.1 List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15
Table 9: Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status 17
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description 17
Table 12: Abbott Vascular Inc. - Ongoing Clinical Trials Overview 18
Table 13: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects who are at Standard Risk for Carotid Endarterectomy with Significant Extracranial Carotid Stenotic Disease (ACT I) 19
Table 14: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 15: Ultrasound-Assisted Thrombectomy System - Product Status 21
Table 16: Ultrasound-Assisted Thrombectomy System - Product Description 21
Table 17: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 18: EmboPRO EPD - Product Status 22
Table 19: EmboPRO EPD - Product Description 22
Table 20: CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 21: CardioGard 22 French Aortic Cannula - Product Status 23
Table 22: CardioGard 22 French Aortic Cannula - Product Description 23
Table 23: CardioLogical Solutions Pipeline Products & Ongoing Clinical Trials Overview 24
Table 24: Emboline CAP - Product Status 25
Table 25: Emboline CAP - Product Description 25
Table 26: Claret Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 27: Sentinel Cerebral Protection System - Product Status 27
Table 28: Sentinel Cerebral Protection System - Product Description 27
Table 29: Claret Medical, Inc. - Ongoing Clinical Trials Overview 28
Table 30: Sentinel Cerebral Protection System - Cerebral Protection in Transcatheter Aortic Valve Replacement - The SENTINEL Study 29
Table 31: Sentinel Cerebral Protection System - Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement 29
Table 32: Gardia Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 33: WIRION Embolic Protection System - Product Status 31
Table 34: WIRION Embolic Protection System - Product Description 31
Table 35: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 32
Table 36: Emblok Embolic Protection Catheter - Product Status 33
Table 37: Emblok Embolic Protection Catheter - Product Description 33
Table 38: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Table 39: Permanently Implantable Embolic Balloon - Product Status 34
Table 40: Permanently Implantable Embolic Balloon - Product Description 34
Table 41: Keystone Heart Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 42: SHEF II - Dual Purpose Device - Product Status 35
Table 43: SHEF II - Dual Purpose Device - Product Description 35
Table 44: TriGuard Cerebral Protection Device - Product Status 36
Table 45: TriGuard Cerebral Protection Device - Product Description 36
Table 46: Keystone Heart Ltd. - Ongoing Clinical Trials Overview 37
Table 47: TriGuard Cerebral Protection Device - A Prospective Multicenter Randomized Trial of Triguard Neuro Protection Versus no Protection In Patients Undergoing TAVR 38
Table 48: TriGuard Cerebral Protection Device - A Prospective, Randomized Evaluation of the TriGuard HDH Embolic Deflection Device During Transcatheter Aortic Valve Implantation 38
Table 49: TriGuard Cerebral Protection Device - A Prospective, Single Arm Feasibility Pilot Study to Evaluate the Safety and Performance of the TriGuard HDH Embolic Deflection Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR) 39
Table 50: TriGuard Cerebral Protection Device - A Prospective, Single Arm Feasibility Study to Evaluate the Safety and Performance of the SMT Embolic Deflection Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR) 39
Table 51: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 52: SilverHawk With SpiderFX Embolic Protection Device - Product Status 41
Table 53: SilverHawk With SpiderFX Embolic Protection Device - Product Description 41
Table 54: Medtronic plc - Ongoing Clinical Trials Overview 42
Table 55: SilverHawk With SpiderFX Embolic Protection Device - Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study 43
Table 56: Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
Table 57: Blockstent Microcatheter - Product Status 45
Table 58: Blockstent Microcatheter - Product Description 45
Table 59: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 60: Aortic Embolic Protection Device - Product Status 47
Table 61: Aortic Embolic Protection Device - Product Description 47
Table 62: NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview 48
Table 63: NIT Thrombectomy Catheter - Product Status 49
Table 64: NIT Thrombectomy Catheter - Product Description 49
Table 65: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 66: Protection Collar - Product Status 51
Table 67: Protection Collar - Product Description 51
Table 68: Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 69: TAVIPro - Product Status 53
Table 70: TAVIPro - Product Description 53
Table 71: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 72: SESAME Stent - Product Status 55
Table 73: SESAME Stent - Product Description 55
Table 74: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 56
Table 75: Transcatheter Device - Atherosclerotic Plaque - Product Status 57
Table 76: Transcatheter Device - Atherosclerotic Plaque - Product Description 57
Table 77: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 58
Table 78: Embolic Protection Device - Product Status 59
Table 79: Embolic Protection Device - Product Description 59
Table 80: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 60
Table 81: Minimally Invasive Thrombectomy Device - Product Status 61
Table 82: Minimally Invasive Thrombectomy Device - Product Description 61
Table 83: Glossary 71

1.2 List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13

【掲載企業】

Abbott Vascular Inc.
AngioDynamics, Inc.
Cardio-Flow Ltd.
CardioGard Ltd.
CardioLogical Solutions
Claret Medical, Inc.
Gardia Medical Ltd.
Innovative Cardiovascular Solutions, LLC
Innovia LLC
Keystone Heart Ltd.
Medtronic plc
Metactive Medical, LLC
MIV Therapeutics Inc
NeuroInterventions
Neurosonix Ltd.
Nexeon MedSystems, Inc.
Palmaz Scientific, Inc.
Trinity College Dublin
University of Minnesota
University of Toledo

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界における末梢塞栓保護デバイスの製品パイプライン動向2015(Peripheral Embolic Protection Devices - Pipeline Review, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆